NorthWest Biotherapeutics Inc (NWBO)

[Roman516]

Since 2019, NWBO has risen 250%
"But yet the NWBO stock has gone NOWHERE since the release of the TLD data. NVCR has been very positive for it's shareholders since it's first Phase 3 GBM trial data was released. Even with the recent decline it is still been very lucrative if you were holding before the 1st Phase trial results were released. NWBO sure can't say that regardless of their exchange." this is bogus news but, NVCR has dropped 40%.